| CEO Name | Bill Linton |
| Nationality | United States |
| Net Worth Estimation | $500 million |
Bill Linton's estimated net worth of around $500 million stems from his founding stake and ongoing leadership in Promega Corporation, a major global supplier of biotechnology and life science research products. His wealth is driven by Promega's sustained growth, private ownership structure, and expansive product portfolio for scientific and medical research.
Bill Linton's estimated net worth of $500,000,000 significantly exceeds the typical biotechnology CEO range of $10,000,000 to $80,000,000, surpassing the category's maximum by 525%. His net worth is more than six times higher than the highest estimated CEO net worth in the field.
Business Category: Biotechnology
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD
Bill Linton Performance in Promega Corporation
Bill Linton, CEO of Promega Corporation, demonstrates visionary leadership that drives innovation and strategic growth in the biotechnology sector. His decision-making emphasizes research advancement and customer-centric solutions, resulting in consistent performance improvements and market expansion. Under Linton's guidance, Promega has solidified its industry reputation, increased global reach, and fostered a culture of scientific excellence.
Latest News
Promega Corporation Collaborates and Faces Legal Challenges Under CEO Bill Linton
Promega Corporation, a leading life science solutions company based in Madison, WI, continues to innovate through partnerships with MilliporeSigma for 3D cell drug discovery and Watchmaker Genomics for enzyme technology, while CEO and founder Bill Linton navigates significant legal disputes involving minority shareholders over company direction and control, including a recent $300 million settlement and ongoing lawsuits. Linton emphasizes maintaining Promega's independence and long-term growth without mergers, reinforcing his vision for the company's future.
Source: http://www.promega.com/aboutus/press-releases/ and http://www.biospace.com/promega-corporation-ceo-b-linton-b-return-fire-in-legal-battle-with-shareholders